Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with confidence interval,…
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: Complete Statistical AnalysisIndependent statistical analysis of To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: Complete Statistical AnalysisIndependent statistical analysis of To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TOBA II BTKIndependent statistical analysis of Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tobacco Cessation at FDNY: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Cessation at FDNY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05997225).
- Tobacco Use Treatment in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Use Treatment in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03482583).
- TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: Complete Statistical AnalysisIndependent statistical analysis of TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tocilizumab for Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01450137).
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tocilizumab for the Treatment of Behcet’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Treatment of Behcet's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693653).
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib for the Treatment of Alopecia Areata and Its Variants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312882).
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03793439).
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: Complete Statistical AnalysisIndependent statistical analysis of Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02138461).
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): Complete Statistical AnalysisIndependent statistical analysis of Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolvaptan for Ascites in Cirrhotic Patients: Complete Statistical AnalysisIndependent statistical analysis of Tolvaptan for Ascites in Cirrhotic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01292304).
- TOMOIndependent statistical analysis of Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TOP 1501Independent statistical analysis of Neoadjuvant Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02818920).
- TOP1201 IPIIndependent statistical analysis of Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence…
- TOPAZIndependent statistical analysis of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.: primary endpoint results, effect estimate with confidence interval, sample-size…
- TOPAZ-IIndependent statistical analysis of A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV)…
- Topera C-FIRM Registry: Complete Statistical AnalysisIndependent statistical analysis of Topera C-FIRM Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02407249).
- Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02664909).
- Topical Antibiotics and Intravitreous Injections: Complete Statistical AnalysisIndependent statistical analysis of Topical Antibiotics and Intravitreous Injections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00410891).
- Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ): Complete Statistical AnalysisIndependent statistical analysis of Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05269160).
- Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855607).
- Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC): Complete Statistical AnalysisIndependent statistical analysis of Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Topical Ruxolitinib Evaluation in Chronic Hand Eczema: Complete Statistical AnalysisIndependent statistical analysis of Topical Ruxolitinib Evaluation in Chronic Hand Eczema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05906628).
- Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD): Complete Statistical AnalysisIndependent statistical analysis of Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395340).
- Topical Treatment and Prevalence of P. Acnes: Complete Statistical AnalysisIndependent statistical analysis of Topical Treatment and Prevalence of P. Acnes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257202).
- Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TOPPSIndependent statistical analysis of Toronto Thromboprophylaxis Patient Safety Initiative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01869075).
- TOPSIndependent statistical analysis of Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity): primary endpoint results, effect…
- Torlak-300Independent statistical analysis of Phase 3 Trial of Serbian Seasonal Influenza Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02935192).
- Torsion of the Tibial Tuberosity, a New Factor of Patellar Instability?: Complete Statistical AnalysisIndependent statistical analysis of Torsion of the Tibial Tuberosity, a New Factor of Patellar Instability?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement: Complete Statistical AnalysisIndependent statistical analysis of Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM): Complete Statistical AnalysisIndependent statistical analysis of Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression: Complete Statistical AnalysisIndependent statistical analysis of Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05371041).
- TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma: Complete Statistical AnalysisIndependent statistical analysis of TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TPTNS for Treating Patients With Premature Ejaculation: Complete Statistical AnalysisIndependent statistical analysis of TPTNS for Treating Patients With Premature Ejaculation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03204890).
- TrACERIndependent statistical analysis of S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02728596).
- TRACTORIndependent statistical analysis of Ticagrelor Therapy for RefrACTORy Migraine Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02518464).
- TRANQUILITYIndependent statistical analysis of A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…